Jefferies Group LLC Uni Qure N.V. Put Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	BUY	$13.15 - $20.45 $39,450 - $61,350	3,000 Added 7.04%	45,600 $849,000
Q2 2022 Aug 15, 2022	BUY	$13.15 - $20.45 $39,450 - $61,350	3,000 Added 7.04%	45,600 $850,000
Q4 2021 Sep 21, 2023	SELL	$20.24 - $36.01 $60,719 - $108,030	-3,000 Reduced 6.58%	42,600 $883,000
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $149,776 - $266,474	-7,400 Reduced 14.8%	42,600 $884,000
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $1.8 Million - $2.38 Million	50,000 New	50,000 $1.84 Million

152

40.4M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $736M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.